Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities.

FK 749 is a new parenteral cephalosporin derivative which is more active against various gram-negative bacilli, including the opportunistic pathogens such as Enterobacter, Citrobacter species, and Serratia marcescens, than cephalosporins and cephamycins such as cefotiam, cefamandole, cefuroxime, cef...

Cijeli opis

Bibliografski detalji

Izdano u:	Antimicrob Agents Chemother
Glavni autori:	Kamimura, T, Matsumoto, Y, Okada, N, Mine, Y, Nishida, M, Goto, S, Kuwahara, S
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1979
Teme:	Research Article
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352902/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/525994/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.16.5.540
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!